title: Body mass index and mortality in CKD.
abstract: BACKGROUND
  Greater body mass index (BMI) is associated with worse survival in the general population, but appears to confer a survival advantage in patients with kidney failure treated by hemodialysis. Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD).
  
  
  METHODS
  Cohort study.
  
  
  METHODS
  The Modification of Diet in Renal Disease (MDRD) Study examined the effects of dietary protein restriction and blood pressure control on progression of kidney disease. This analysis includes 1,759 subjects.
  
  
  METHODS
  BMI.
  
  
  METHODS
  Cox models were used to evaluate the relationship of quartiles of BMI with all-cause and cardiovascular disease (CVD) mortality.
  
  
  RESULTS
  Mean GFR and BMI were 39 +/- 21 (SD) mL/min/1.73 m(2) and 27.1 +/- 4.7 kg/m(2), respectively. During a mean follow-up of 10 years, there were 453 deaths (26%), including 272 deaths (16%) from CVD. In unadjusted Cox models, quartiles 3 (hazard ratio [HR], 1.45; 95% confidence interval [CI], 1.11 to 1.90) and 4 (HR, 1.58; 95% CI, 1.21 to 2.06) were associated with increased risk of all-cause mortality compared with quartile 1. Adjustment for demographic, CVD, and kidney disease risk factors and randomization status attenuated this relationship for quartiles 3 (HR, 0.81; 95% CI, 0.60 to 1.09) and 4 (HR, 0.83; 95% CI, 0.61 to 1.20). In unadjusted Cox models, quartiles 3 (HR, 1.66; 95% CI, 1.17 to 2.36) and 4 (HR, 1.63; 95% CI, 1.15 to 2.33) were associated with increased risk of CVD mortality. Multivariable adjustment attenuated this relationship for quartiles 3 (HR, 0.92; 95% CI, 0.63 to 1.36) and 4 (HR, 0.85; 95% CI, 0.57 to 1.27).
  
  
  CONCLUSIONS
  Primary analyses were based on single measurement of BMI. Because the MDRD Study cohort included relatively young white subjects with predominantly nondiabetic CKD, results may not be generalizable to all patients with CKD.
  
  
  CONCLUSIONS
  In this cohort of subjects with predominantly nondiabetic CKD, BMI does not appear to be an independent predictor of all-cause or CVD mortality.
authors.affiliation: Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Madero
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Sarnak
authors.forename: Xuelei
authors.initials: X
authors.lastname: Wang
authors.forename: Carmen Castaneda
authors.initials: CC
authors.lastname: Sceppa
authors.forename: Tom
authors.initials: T
authors.lastname: Greene
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Beck
authors.forename: John W
authors.initials: JW
authors.lastname: Kusek
authors.forename: Allan J
authors.initials: AJ
authors.lastname: Collins
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Levey
authors.forename: Vandana
authors.initials: V
authors.lastname: Menon
mesh_terms: D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000150:complications; D002908:Chronic Disease; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000401:mortality*; D008297:Male; D008875:Middle Aged